Moreover, the release of tumor-associated antigens (TAAs) or tumor-specific antigens (TSAs) from damaged tumor cells and their subsequent presentation by antigen-presenting cells (APCs) stimulate adaptive immune responses, which involve the activation of antigen-specific CD4+ and CD8+ T cells (84, 85). This evidence concerns the gene CD8A and neoplasm.